China to launch unmanned probe to Mars today
BEIJING: China will aim to launch its first independent mission to Mars today (Thursday) as it gears up to take the leadership in space...
Biden says intelligence briefings warn of possible Russian meddling in elections
WASHINGTON: Joe Biden, presumptive democratic presidential nominee has said that he had received intelligence briefings based on which it was clear that Russia was...
China battles record flood by heavy rain; dozens reported dead, 433 rivers burst banks
BEIJING: As many as 433 rivers in China have risen to their highest levels in history after days of torrential rain, a senior water...
Trump administration reverses visa policy on foreign students
WASHINGTON: The Trump administration will not force foreign students to leave the United States even if all of their classes are to be taught...
WHO advance team on way to China to set up probe into virus origin
GENEVA: An advance team from the World Health Organization (WHO) has left for China to organize an investigation into the origins of the novel...
Japan will not revive state of emergency as Tokyo COVID- 19 cases rise
TOKYO: Japan has no need to reintroduce a state of emergency to tackle the novel coronavirus, its top government spokesman said on Friday, as...
Chinese parliament unanimously passes Hong Kong security law
BEIJING: The Chinese Parliament unanimously passed the Hong Kong security law, drawing international condemnation.
Media reports quoting sources, said the law was passed unanimously by...
China to safeguard its territorial authority at all cost: Spokesperson
BEIJING: A spokesperson of the Chinese foreign Ministry Zhao Lijian reiterated that his country will safeguard its territorial and administrative authority in Hong Kong...
Vietnam grounds Pakistani pilots over licence concerns
HANOI: Vietnam’s aviation authority said on Monday it had grounded all Pakistani pilots working for local airlines, amid concern from global regulators that some...
Gilead targets 2 million remdesivir courses by year-end
WASHINGTON: Gilead Sciences has said it expects supply of its potential COVID-19 drug remdesivir to exceed two million courses by year-end, more than double...
